Evidence map›Paper›PMID 42382482›Full record

ArticleBulletin of the World Health Organization2026

Evaluation of an application for investments in cataract surgery, Ethiopia.

Dominque Geoffrion, Noelle Whitestone, Jennifer L Patnaik, Samson Tesfaye, Dawit Seyum, Nigusie Fetene, Enock Nsokolo, Lucia Nadaf, Ruth Nswana, Alemayehu Sisay and 5 more

Abstract read
In one paragraph

Article in Bulletin of the World Health Organization, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Dominque GeoffrionDepartment of Ophthalmology, University of Montreal, Montreal, Quebec, Canada.
Noelle WhitestoneOrbis International, 8th Floor, 52 Vanderbilt Ave, New York, NY10017, United States of America (USA).
Jennifer L PatnaikDepartment of Ophthalmology, University of Colorado School of Medicine, Aurora, Colorado, USA.
Samson TesfayeOrbis Ethiopia, Addis Ababa, Ethiopia.
Dawit SeyumOrbis Ethiopia, Addis Ababa, Ethiopia.
Nigusie FeteneOrbis Ethiopia, Addis Ababa, Ethiopia.
Enock NsokoloOrbis Zambia, Lusaka, Zambia.
Lucia NadafOrbis Zambia, Lusaka, Zambia.
Ruth NswanaOrbis Zambia, Lusaka, Zambia.
Alemayehu SisayOrbis Ethiopia, Addis Ababa, Ethiopia.
David H CherwekOrbis International, 8th Floor, 52 Vanderbilt Ave, New York, NY10017, United States of America (USA).
Serge ResnikoffSchool of Optometry and Vision Science, Faculty of Medicine, University of New South Wales, Sydney, Australia.
Phylis MoongaMinistry of Health, Lusaka, Zambia.
Jonathan NcheengamwaKonkola Mine Hospital, Chililabombwe, Zambia.
Nathan CongdonOrbis International, 8th Floor, 52 Vanderbilt Ave, New York, NY10017, United States of America (USA).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Problem: The World Health Organization recommends a benchmark for uncorrected visual acuity of ≥ 6/12 in 80% of patients at 4 to 6 weeks following cataract surgery. In low-resource countries, reaching this benchmark is challenging and assessing progress is difficult. Approach: This intervention involved modest investments recommended by the Better Operative Outcome Software Tool (BOOST) application (app). The investments targeted specific causes of poor cataract surgery results at hospitals in Ethiopia to improve vision outcomes. Fifteen ophthalmic surgeons from 11 public secondary and tertiary eye care centres in five regional Ethiopian states collected pre-intervention data using the BOOST app. Based on 20 consecutive patients with vision < 6/60, BOOST identified case selection, intraoperative complications or postoperative refractive error as the leading causes of poor outcomes. Each facility then invested 2500 United States dollars (US$) to target its leading cause, recorded outcomes for 60 consecutive cataract patients, and then compared the proportion with uncorrected vision ≥ 6/12 before and after the intervention. Local setting: All 11 centres are Orbis International partners and services provided at the facilities are highly subsidized or free of charge. Relevant changes: After implementing targeted interventions at the facilities to address undetected ocular comorbidity, surgical complications or postoperative refractive errors, 501 (56.0%) of 894 patients had good results (≥ 6/12), compared to 289 (32.2%) of 897 patients before the intervention. Lessons learnt: Using the BOOST app as an approach for quality monitoring and improvement enables benchmarking across contexts and can enhance surgical outcomes when paired with recommended targeted investments.

Indexed as

Cataract ExtractionAgedBenchmarkingEthiopiaFemaleHumansMaleMiddle AgedPostoperative ComplicationsVisual Acuity

Identifiers

PMID42382482
PMCPMC13318370

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.